company background image

Reliq Health Technologies TSXV:RHT Stock Report

Last Price


Market Cap







24 Jun, 2022


Company Financials
RHT fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health4/6

RHT Stock Overview

Reliq Health Technologies Inc., a telemedicine company, develops virtual care solutions for the healthcare market.

Reliq Health Technologies Competitors













Price History & Performance

Summary of all time highs, changes and price drops for Reliq Health Technologies
Historical stock prices
Current Share PriceCA$0.50
52 Week HighCA$1.33
52 Week LowCA$0.42
1 Month Change-9.09%
3 Month Change-40.48%
1 Year Change11.11%
3 Year Change92.31%
5 Year Change316.67%
Change since IPO-96.00%

Recent News & Updates

Shareholder Returns

RHTCA Healthcare ServicesCA Market

Return vs Industry: RHT exceeded the Canadian Healthcare Services industry which returned -56.2% over the past year.

Return vs Market: RHT exceeded the Canadian Market which returned -5.7% over the past year.

Price Volatility

Is RHT's price volatile compared to industry and market?
RHT volatility
RHT Average Weekly Movement10.2%
Healthcare Services Industry Average Movement13.6%
Market Average Movement9.9%
10% most volatile stocks in CA Market17.2%
10% least volatile stocks in CA Market4.3%

Stable Share Price: RHT is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: RHT's weekly volatility (10%) has been stable over the past year.

About the Company

2005n/aLisa Crossley

Reliq Health Technologies Inc., a telemedicine company, develops virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016.

Reliq Health Technologies Fundamentals Summary

How do Reliq Health Technologies's earnings and revenue compare to its market cap?
RHT fundamental statistics
Market CapCA$94.29m
Earnings (TTM)-CA$9.42m
Revenue (TTM)CA$6.66m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RHT income statement (TTM)
Cost of RevenueCA$1.93m
Gross ProfitCA$4.73m
Other ExpensesCA$14.15m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Oct 28, 2022

Earnings per share (EPS)-0.05
Gross Margin71.03%
Net Profit Margin-141.28%
Debt/Equity Ratio0.6%

How did RHT perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.


Is RHT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 1/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RHT?

Other financial metrics that can be useful for relative valuation.

RHT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue14.1x
Enterprise Value/EBITDA-10.3x
PEG Ration/a

Price to Sales Ratio vs Peers

How does RHT's PS Ratio compare to its peers?

RHT PS Ratio vs Peers
The above table shows the PS ratio for RHT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average26.3x

Price-To-Sales vs Peers: RHT is good value based on its Price-To-Sales Ratio (14.1x) compared to the peer average (26.3x).

Price to Earnings Ratio vs Industry

How does RHT's PE Ratio compare vs other companies in the Canadian Healthcare Services Industry?

Price-To-Sales vs Industry: RHT is expensive based on its Price-To-Sales Ratio (14.1x) compared to the Canadian Healthcare Services industry average (5.1x)

Price to Sales Ratio vs Fair Ratio

What is RHT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RHT PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio14.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate RHT's Price-To-Sales Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of RHT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate RHT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate RHT's fair value for valuation analysis.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate RHT's PEG Ratio to determine if it is good value.

Discover undervalued companies

Future Growth

How is Reliq Health Technologies forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Reliq Health Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

  • Examine Reliq Health Technologies's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • Reliq Health Technologies competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has Reliq Health Technologies performed over the past 5 years?

Past Performance Score


Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: RHT is currently unprofitable.

Growing Profit Margin: RHT is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: RHT is unprofitable, and losses have increased over the past 5 years at a rate of 12.5% per year.

Accelerating Growth: Unable to compare RHT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RHT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (0.7%).

Return on Equity

High ROE: RHT has a negative Return on Equity (-135.57%), as it is currently unprofitable.

Discover strong past performing companies

Financial Health

How is Reliq Health Technologies's financial position?

Financial Health Score


Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: RHT's short term assets (CA$8.9M) exceed its short term liabilities (CA$1.9M).

Long Term Liabilities: RHT's short term assets (CA$8.9M) exceed its long term liabilities (CA$203.3K).

Debt to Equity History and Analysis

Debt Level: RHT has more cash than its total debt.

Reducing Debt: RHT had negative shareholder equity 5 years ago, but is now positive and has therefore improved.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: RHT has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: RHT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.4% each year

Discover healthy companies


What is Reliq Health Technologies's current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate RHT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate RHT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if RHT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if RHT's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as RHT has not reported any payouts.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Lisa Crossley





Dr. Lisa Crossley PhD, P.Eng. has been Chief Executive Officer of Reliq Health Technologies Inc. since January 18, 2016. Dr. Crossley was Chief Executive Officer of VitalHub Corp. Dr. Crossley served as Ch...

CEO Compensation Analysis

Compensation vs Market: Lisa's total compensation ($USD198.80K) is about average for companies of similar size in the Canadian market ($USD175.39K).

Compensation vs Earnings: Lisa's compensation has increased whilst the company is unprofitable.

Leadership Team

Experienced Management: RHT's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.

Board Members

Experienced Board: RHT's board of directors are considered experienced (4.6 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: RHT insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10%.

Top Shareholders

Company Information

Reliq Health Technologies Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Reliq Health Technologies Inc.
  • Ticker: RHT
  • Exchange: TSXV
  • Founded: 2005
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: CA$94.290m
  • Shares outstanding: 188.58m
  • Website:


  • Reliq Health Technologies Inc.
  • 175 Longwood Road South
  • Suite 406A
  • Hamilton
  • Ontario
  • L8P 0A1
  • Canada


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/24 00:00
End of Day Share Price2022/06/24 00:00
Annual Earnings2021/06/30

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.